Regeneron Investor

Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.

Headquarters: Tarrytown, New York, United States
Investors Number: NA
Technology: Others
Last Funding Type: Post-IPO Equity
Zip: NA
Total Funding: 8900000.0
Last Funding Date: 2016-08-22
Founded Date: 1988-01-01
Industry: Biopharma
Estimated Revenue: $1B to $10B
Acquisitions Number: Made Acquisitions